Table 5: Treatment and outcomes.
Treatment of NPSLE |
n(%) |
Intravenous methyl prednisolone Cyclophosphamide Mycophenolate mofetil Rituximab Intravenous Immunoglobulin Plasmapheresis Antiplatelet Anticoagulant Anticonvulsant Psychiatric treatment |
13(72.2) 10(66.7) 5(27.8) 4(22.2) 2(11.1) 1(5.6) 3(16.7) 2(11.1) 5(27.8) 3(16.7) |
Outcomes |
n(%) |
Clinical improvement Relapsing NPSLE Death Diffuse alveolar hemorrhage Ischaemic heart disease Unknown |
12(66.7) 3(16.7) 3(16.7) 1(5.6) 1(5.6) 1(5.6) |